Featured Product Partner the leva Pelvic Health System

UI negatively impacts women’s quality of life and can contribute to other potentially severe medical conditions. Despite its prevalence and adverse effects on women’s health, UI is often underreported by women and thus not addressed by many clinicians. Fortunately, groups such as ACOG (American College of Obstetricians and Gynecologists) and WPSI (Women’s Preventive Services Initiative) are increasingly recommending screening for pelvic floor disorders including UI. Early intervention has been shown to resolve or reduce symptoms, improve immediate and long-term condition-specific quality of life, and limit the need for more invasive and costly treatments.

The leva Pelvic Health System offers a novel, non-invasive, medication-free way for women to train and strengthen their pelvic floor muscles—at home in just five minutes a day—to treat urinary incontinence. Combining a small FDA-cleared vaginal wand connected to a smartphone app, leva offers precise visualization of pelvic movement in real-time, enables progress tracking and allows active physician involvement, all of which support a women’s success.

leva is available by prescription, allowing physicians the opportunity to treat UI on a broad scale and with continued involvement in patient success. Published data from globally recognized medical centers support leva’s efficacy. The Digital Therapeutics Alliance, a global, non-profit organization that advances quality digital therapeutics in healthcare, includes leva in its Product Library, indicating that it meets DTA’s rigorous definition of an evidence-based digital therapeutic and satisfies its ten rigorous Core Principles. Renovia is the first company focused solely on women’s health to have a product included in the DTA Product Library.